| Literature DB >> 36115674 |
Svetlana Solgaard Nielsen1,2, Søren T Skou2,3, Anette Enemark Larsen4, Romanas Polianskis5, Wojciech Zbigniew Pawlak5, Henrik Bjarke Vægter6,7, Jens Søndergaard8, Jeanette Reffstrup Christensen9,8,10.
Abstract
OBJECTIVES: To evaluate the feasibility and outcomes of an occupational therapy lifestyle intervention for adults living with chronic pain.Entities:
Keywords: COMPLEMENTARY MEDICINE; PAIN MANAGEMENT; PUBLIC HEALTH; REHABILITATION MEDICINE
Mesh:
Substances:
Year: 2022 PMID: 36115674 PMCID: PMC9486323 DOI: 10.1136/bmjopen-2022-060920
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Research progression criteria for feasibility outcomes
| Feasibility outcomes | Evaluation source | Decision/action to be taken† | ||
| Continue | Solve | Stop | ||
| Recruitment rate | Number recruited per month (n per group) | n≥3 (5) | n=2 (2) | n=1 (1) |
| Participant retention | Completion rates | ≥80% | 75%–79.9% | <75% |
| Programme adherence greater than 75% of sessions | Adherence rates | ≥75% | 50%–74.9% | <50% |
| Patients’ self-perceived relevance, timing and mode of delivery | Patient evaluations (positive) | ≥75% | 50%–74.9% | <50% |
| Assessment procedure* acceptance | Patient evaluations | ≥75% | 50%–74.9% | <50% |
| Adverse events, % discontinued | Patient journals and PainData | 0% | 0.1%–9.9% | ≥10% |
| Fidelity of delivery | Process evaluations | ≥90% | 50%–89.9% | <50% |
*Assessment procedure planned for the randomised controlled trial (RCT) included: (a) completion of PainData standard questionnaire with an attachment (developed for the project purposes) assessing sociodemographics, quality of life, pain self-efficacy, pain intensity, pain catastrophising, pain localisation and sleep quality; (b) interview-based assessment of occupational performance and participation; (c) measuring blood pressure, waist circumference and bioimpedance; (d) cuff algometry; and (e) actigraphy for physical wake time activity (see online supplemental appendix 4 for the assessment tools used).
†Colors correspond with the red ('Stop')-amber ('Solve')-green ('Continue') method.
Figure 1Study flow diagram. REVEAL(OT), Redesign Your Everyday Activities and Lifestyle with Occupational Therapy.
Sociodemographic and health-related characteristics of the study cohort
| Variable | Count (%) or mean (median; range) |
| Females | |
| Study sample (n=40) | 34 (85.0) |
| Discontinued groups (n=17) | 15 (88.2) |
| Not included (n=117) | 81 (69.2) |
| Age (years) | |
| Study sample (n=40) | 46.6 (10.9; 23–64) |
| Discontinued groups (n=17) | 47.4 (10.3; 22–63) |
| Not included (n=117) | 45.8 (10.7; 22–63) |
| Age group, years (n=40) | |
| 18–24 | 1 (2.5) |
| 25–34 | 6 (15.0) |
| 35–44 | 9 (22.5) |
| 45–54 | 12 (30.0) |
| 55–64 | 12 (30.0) |
| Years with pain (n=35) | 9.7 (8.7; 0.7–29.9) |
| <5 | 13 (37.1) |
| 5–9 | 8 (22.9) |
| 10–14 | 3 (8.6) |
| 15–19 | 6 (17.1) |
| ≥20 | 5 (14.3) |
| Self-evaluated health, EQ-5D VAS 0–100 (n=36) | 48.6 (20.2; 6–90) |
| 0–24 | 5 (13.9) |
| 25–49 | 17 (47.2) |
| 50–74 | 11 (30.6) |
| 75–100 | 3 (8.3) |
| Self-evaluated HRQoL, EQ-5D Index (n=35) | 0.464 (−0.109; 0.704) |
EQ-5D, EuroQol-5 Dimension; HRQoL, health-related quality of life; VAS, visual analogue scale.
Research progression criteria summary
| Research progression criteria | Total‡ | Feasibility rounds‡ | Evaluation | Considerations and comments | ||
| 1.0 | 2.0 | 3.0 | ||||
| Recruitment rate (mean number recruited (referred) per month; n per group) | 5.7 (17.5) | 6.7 (28.0) | 4.3 (13.3) | 6.7 (27.3) | Amber/solve | Recruitment n≥3 per month did not guarantee a minimum of 5 in all groups, despite mean 5 per group. With the current recruitment intensity, the recruitment must begin at least ≥2 months before baseline assessment. |
| Participant retention† (n (total), %) | 31 (40) | 9 (9) | 10 (11) | 12 (20) | Green/continue | The lockdown affected the participant retention negatively, solutions allowing the intervention to continue during force majeure situations shall be considered; follow-up assessment completion needs to be secured. |
| Programme adherence greater than 75% of sessions, % mean (range) | 77.5% | 77.8% | 81.8% | 75.0% | Green/continue | Adherence ≤50% of the sessions can occur in few participants and needs attention; self-assessments demand more effective procedure. |
| Patients’ self-perceived relevance, timing and mode of delivery (% mean) | 97.0% | 94.5% | 96.3% | 98.4% | Green/continue | Continuous monitoring is useful; personal preferences may appear; sufficient time for peer discussions shall be provided; afternoon groups may be relevant for some participants. |
| Assessment procedure acceptance (n, %) | 38 (40) | 9 (9) | 9 (11) | 20 (20) | Green/continue | The assessment procedure may need the assessment load reduction; further evaluation of the outcomes may support the improvements; assessment performance needs closer monitoring for timely completion. |
| Adverse events (% caused discontinuation) | 0% | 0% | 0% | 0% | Green/continue | Several participants experienced discomfort from cuff algometry, though none was at health risk or discontinued. |
| Fidelity of delivery (n, % evaluations collected; % contents delivered as planned) | 80.1% | 60.7% | 100% | 100% | Amber/solve | Peer support component may be a barrier in the fidelity of delivery, exceeding the protocolised time of delivery; the intervention providers need flexibility, for example, extra calendar space for new appointments/other problem solving. |
*One participant stopped after baseline assessment.
†Exclusive 17 participants who discontinued involuntarily due to the COVID-19 lockdown.
‡Colors correspond with the red ('Stop')-amber ('Solve')-green ('Continue') method.
Figure 2Participants’ pre-post trajectories in health-related quality of life (EQ-5D-5L, 5-Level version of EuroQol-5 Dimension). REVEAL(OT), Redesign Your Everyday Activities and Lifestyle with Occupational Therapy.
Differences in secondary outcomes pre-post intervention
| Outcomes | n | Baseline | Follow-up | Mean difference | SD | 95% CI | Median (range) | P value | MCID* | |
| HRQoL | 23 | 0.429 | 0.472 | 0.04 | 0.18 | −0.03 | 0.12 | 0.051 (−0.210; 0.432) | 0.2494 | – |
| COPM | ||||||||||
| Performance | 29 | 3.36 | 5.10 | 1.80 | 1.44 | 1.25 | 2.35 | 1.5 (−1.2; 5.4) | < 0.001† | 13.8% |
| Satisfaction | 29 | 2.55 | 4.40 | 1.95 | 2.34 | 1.06 | 2.84 | 1.9 (−1.4; 8.8) | < 0.001† | 24.1% |
*≥3.0 points for performance; ≥3.2 points for satisfaction.
†P<0.001.
COPM, Canadian Occupational Performance Measure; HRQoL, health-related quality of life; MCID, minimal clinically important difference.